AXS-05
AXS-05 is a pharmaceutical drug with 10 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
5
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
8 of 8 finished
0.0%
0 ended early
1
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Assessing Clinical Outcomes in Alzheimer's Disease Agitation
Addressing Dementia Via Agitation-Centered Evaluation
AXS-05 Phase II Trial on Smoking Behavior
Clinical Trials (10)
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Assessing Clinical Outcomes in Alzheimer's Disease Agitation
Addressing Dementia Via Agitation-Centered Evaluation
AXS-05 Phase II Trial on Smoking Behavior
A Trial of AXS-05 in Patients With Major Depressive Disorder
Mechanistic Evaluation of Response in TRD (MERIT)
Assessing Symptomatic Clinical Episodes in Depression
An Evaluation of AXS-05 for the Treatment of TRD in Treatment-Adherent Patients
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive Disorder
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10